In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from conception to final consumer. The key players in the chain are ...

If you're focused on delivering a high return on capital for your shareholders, you should consider M&A as an integral part ...

India’s pharmaceutical sector is at a pivotal moment, with active pharmaceutical ingredients (APIs) presenting a ...

It is estimated that generics account for around 90% of all prescriptions filled in the US, according to the organisation, which claims that the overall value ... the pharma supply chain and ...

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Trade groups representing pharma distributors and generic/biosimilar industries express concerns over potential tariffs on ...